Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development
-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 24, 2022 --...
Expansion Therapeutics News:
Site Under Construction
- Jan 19
Expansion Therapeutics Appoints Gary Bridger, Ph.D., to its Board of Directors
-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 19, 2022 -- Expansion...
252
- Sep 29, 2021
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
-- Funding to advance the company’s SMiRNA™ platform to identify clinical candidates in myotonic dystrophy type 1 (DM1), amyotrophic...
3,135
- Jun 14, 2021
Expansion Therapeutics Names Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery
Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery
164
- May 25, 2021
Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research...
Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research
287
- May 6, 2021
Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research
Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research
129
- Oct 5, 2020
Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President
Meet Expansion Therapeutics New CEO
187